Journal Guide

Journal of Zheijang University SCIENCE B - Biomedicine & Biotechnology is an international journal that presents the latest development and achievements in scientific research in China and abroad to the world’s scientific community. JZUS-B covers research in Biomedicine and Biotechnology and Biochemistry and life science subjects such as Plant and Animal Sciences, Environment and Resources. Research articles, reviews and science letters published in ZJUS-B are peer reviewed by an international editorial board of distinguished foreign and Chinese scientists.

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness, and quality of life. Through information, education, and advocacy APhA empowers its members to improve medication use and advance patient care by:* Providing timely and accurate information that is vital to our members.* Raising societal awareness about the role of pharmacists as essential in patient care for optimal medication use.* Pro viding state-of-the-art resources to enhance our members' continuing professional development.* Educating and influencing legislators, policy makers, regulators, and the public to advance our vision and mission.* Creating unique opportunities for our members to connect and share with their peers across practice settings.

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes mini-reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.Manuscripts should present novel preclinical findings addressing questions of biological significance to human disease. Studies that fail to do so may be rejected without review. Quantitative conclusions must be based on truly quantitative methods. Life Sciences does not publish work on the actions of biological extracts of unknown chemical composition. Compounds studied must be of known chemical structure and concentration. The study must be reproducible; materials used must be available to other researchers so they can repeat the experiment. Clinical studies may be considered if they expand understanding of mechanism, but the journal does not encourage clinical trial reports.Four common reasons for rejection include: out of scope (the manuscript does not conform to the goal of identification of mechanisms related to therapy for human disease); too preliminary (manuscript is based on a limited amount of experimental data diminishing significance); lack of novelty (manuscript is well done but does not address a significant question); unidentified structure (actions of biological extracts of unknown chemical composition).

Marine Drugs publishes reviews, regular research papers and short notes on the research, development and production of drugs from the sea. Our aim is to publish the experimental detail as much as possible, particularly synthetic procedures and characterization information for bioactive compounds. There is no restriction on the length of the experimental section.

http://ees.elsevier.com/mere/Submission of multidisciplinary studies is encouraged. Studies that utilize experimental approaches to clarify the roles of anthropogenic and natural causes of changes in marine ecosystems are especially welcome, as are those studies that represent new developments of a theoretical or conceptual aspect of marine science. All papers published in this journal are reviewed by qualified peers prior to acceptance and publication. Examples of topics considered to be appropriate for the journal include, but are not limited to, the following:

– The extent, persistence, and consequences of change and the recovery from such change in natural marine systems
– The biochemical, physiological, and ecological consequences of contaminants to marine organisms and ecosystems
– The biogeochemistry of naturally occurring and anthropogenic substances
– Models that describe and predict the above processes
– Monitoring studies, to the extent that their results provide new information on functional processes
– Methodological papers describing improved quantitative techniques for the marine sciences.

Materials Advances is an international, gold open access journal, publishing high-quality research across the breadth of materials science. The journal accepts experimental or theoretical studies that report new understanding, applications, properties and synthesis of materials, building on and complementing the materials content already published across the Royal Society of Chemistry journal portfolio. Submissions are handled by our high profile associate editors, all of whom also look after submissions to Journal of Materials Chemistry A, B & C. The Materials Advances publishing experience comes with the reputation, standards, commitment and expertise you would expect from an RSC journal, plus the visibility boost that comes from being open access and part of the Journal of Materials Chemistry family.

Materials Chemistry Frontiers is devoted to the publication of original contributions at the interface of chemistry and materials science, with topics spanning but not limited to energy materials, catalysis, biomaterials, nanoscience, polymers, luminescent materials, and sensors. The journal places an emphasis on original research that demonstrates conceptual advancements with emerging applications, rather than primarily reporting technological improvements. Together with Organic Chemistry Frontiers and Inorganic Chemistry Frontiers, this suite of journals offers an authoritative portfolio that is jointly owned by the Chinese Chemical Society, the Royal Society of Chemistry, and partner institutions.

Formerly the IMA Journal of Mathematics Applied in Medicine and Biology.Mathematical Medicine and Biology publishes original articles with a significant mathematical content addressing topics in medicine and biology. Papers exploiting modern developments in applied mathematics are particularly welcome. The biomedical relevance of mathematical models should be demonstrated clearly and validation by comparison against experiment is strongly encouraged.The journal welcomes contributions relevant to any area of the life sciences including: * biomechanics * biophysics * cell biology * developmental biology * ecology and the environment * epidemiology * immunology * infectious diseases * neuroscience * pharmacology * physiology * population biology.

Medical Cannabis and Cannabinoids is a peer-reviewed journal offering an international forum to present and discuss recent advances in the rapidly developing and challenging field of the medical use of cannabis and cannabinoids. It seeks to bridge the gap between empirical and evidence-based clinical medicine by covering current basic and applied as well as translational research topics. In addition to original papers, reviews, and mini-reviews, this journal features short communications, case reports, technical notes, letters, and conference proceedings.

Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.

Medicinal Chemistry Research is a journal for the prompt disclosure of novel experimental achievements in the many facets of drug design, drug discovery, and the elucidation of mechanisms of action of biologically active compounds. Articles are sought which emphasize research in chemical biological relationships, especially on: structure-activity relationships, investigations of biochemical and pharmacological targets of drug action, and correlations of structures with the mode of action of biologically active compounds. Studies will be welcomed that increase our understanding of biochemical interactions between drug molecules, ions, free radicals, and sterically important sections of macromolecular targets.The journal will strive to publish short papers of approximately 8-10 pages within two months of acceptance. A rapid peer-reviewing system will be maintained by the Editors. In addition, occasional short 'New Trends' articles will appear at the invitation of the Editors. These articles will be solicited fr